📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems. (2024)

First Author: Roberts I

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmj-2024-079444

PubMed Identifier: 38866414

Publication URI: http://europepmc.org/abstract/MED/38866414

Type: Journal Article/Review

Volume: 385

Parent Publication: BMJ (Clinical research ed.)

ISSN: 0959-8138